Maplelane Capital’s Clorox CLX Stock Holding History

Maplelane Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-170,000	Closed	-$25.3M	–	143
2017 Q4	$25.3M	Buy	+170,000	New	+$23.1M	0.55%	49
2014 Q1	–	Sell	-660,000	Closed	-$61.2M	–	139
2013 Q4	$61.2M	Buy	+660,000	New	+$59.4M	2.46%	12

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

VAM

ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Maplelane Capital's CLX Position: Q1 2018 in Review

Maplelane Capital sold out of Clorox (CLX) in Q1 2018, closing a stake of 1 share.

Maplelane Capital first reported a position in CLX in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 913 funds tracked by Wall St. Rank hold CLX as of Q1 2018.

Maplelane Capital reported no remaining Clorox position as of Q1 2018 after selling out during the quarter.
Maplelane Capital sold 1 Clorox share in Q1 2018.
Maplelane Capital first reported a position in Clorox in Q4 2017 and held it in 1 quarter.
Maplelane Capital's Clorox position peaked at $0 in Q4 2017.
913 funds tracked by Wall St. Rank held Clorox as of Q1 2018.

Based on Maplelane Capital's 13F filing for Q1 2018, filed 15 May 2018.